Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Consolidated Diluted EPS At -1.1029

0

For the year ended 2015-12-31 Xenon Pharmaceuticals Inc. (NASDAQ:XENE) basic consolidated EPS came $-1.1029. Furthermore, for the quarter closed 2015-12-31, it was $-1.1029.

Consolidated diluted EPS

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) consolidated diluted EPS was -1.1029 for the year ended 2015-12-31. For the quarter ended 2015-12-31, it stood at $-1.1029.

EPS contribution from parent

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) basic EPS was $-1.1029 for the year ended 2015-12-31 from its parent entity. It was $-1.1029 for the quarter closed 2015-12-31.

EPS from continuing operations

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) EPS from continuing activities was $-1.1029 for the fiscal ended 2015-12-31. For the quarter ended 2015-12-31, this figure was $-1.1029.

Basic net EPS

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) basic net EPS was $-1.1 for the year ended 2015-12-31. For the quarter ended 2015-12-31, it came at $-1.1.

Diluted EPS from parent

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) diluted EPS from parent entity came at $-1.1029 for the year ended 2015-12-31. For the quarter ended 2015-12-31 it was $-1.1029.

Net diluted EPS

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) net diluted EPS was $-1.1 for the fiscal closed 2015-12-31. For the quarter ended 2015-12-31, net diluted EPS was $-1.1.

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) net basic EPS was $-1.1 for the year ended 2015-12-31. For the quarter ended 2015-12-31, it was $-1.1.

Basic diluted EPS

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) basic diluted EPS was $-0.2267 for the quarter ended 2015-12-31. For the year ended 2015-12-31, basic diluted EPS was $-0.2267.

For the year ended 2015-12-31, basic shares outstanding were 14.282 while for the quarter ended 2015-12-31 is 14.282.

For the fiscal ended 2015-12-31, the diluted outstanding shares were 14.282 and for the quarter ended 2015-12-31 it was 14.282. Earnings per share and diluted EPS are profitability metrics used in fundamental analysis of firms. EPS just takes into account a firm’s common shares, while diluted EPS considers all convertible securities. Per-share earnings measure the quantum of a company’s earnings on a per share basis. Basic EPS does not consider any dilutive impact that convertible securities leave on EPS. On contrary, diluted EPS is a tool used in fundamental study to gauge a firm’s quality of EPS, assuming there is conversion of all convertible securities.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 11 times, 1 visits today)